Celltrion Pharm, Up 13.41% Amid K-New Deal Index (Bio) Theme Surge

On the 28th, the K-New Deal Index (Bio) theme showed a strong performance, rising 3.86% compared to the previous day, while Celltrion Pharm, gaining attention as a related stock, surged 13.41% from the previous day. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.

[Graph] K-New Deal Index (Bio) Theme Major Stocks Price Change Rates

According to the analysis by Thinkpool Robo Algorithm RASSI, Celltrion Pharm's quant financial score is 30.36 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to the K-New Deal Index (Bio). This can be interpreted as Celltrion Pharm having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Seegene ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme

※ The quant financial score is the result of the robo algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.